By expenditures
| Name | Title | Type |
|---|---|---|
| Rebekah Le | Interim Chief Operating Officer | Auditee |
| Jansen Otterness | Partner | Auditee |
| Delayna Judy | VP of Accounting | Auditee |
| Ben Glisan | CHIEF FINANCIAL OFFICER | Auditee |
| Jeff Allen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 363301 | 2024 | 2025-07-29 | Forvis Mazars LLP | $20.46M |
| 300967 | 2023 | 2024-03-29 | Forvis LLP | $34.03M |
| 18977 | 2022 | 2023-03-28 | Forvis LLP | $32.40M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 363301 | 2024 | 2025-07-29 | 1148642 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148641 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148640 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148639 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148638 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148637 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148636 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148635 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148634 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148633 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 1148632 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148631 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148630 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148629 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148628 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148627 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148626 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148625 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148624 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148623 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148622 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 1148621 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572200 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572199 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572198 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572197 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572196 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572195 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572194 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572193 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572192 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572191 | 2024-003 | Significant Deficiency | - | E |
| 363301 | 2024 | 2025-07-29 | 572190 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572189 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572188 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572187 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572186 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572185 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572184 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572183 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572182 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572181 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572180 | 2024-002 | Material Weakness | - | B |
| 363301 | 2024 | 2025-07-29 | 572179 | 2024-002 | Material Weakness | - | B |